Research graph
References from Vepdegestrant: the first FDA-approved oral PROTAC and a milestone in targeted protein degradation. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1038/s41580-024-00729-9
10.1038/s41580-024-00729-9 · 2024 · External reference
10.1038/s41568-025-00817-8
10.1038/s41568-025-00817-8 · 2025 · External reference
10.1073/pnas.141230798
10.1073/pnas.141230798 · 2001 · External reference
Unresolved reference
External reference
10.1158/1078-0432.ccr-23-3465
10.1158/1078-0432.ccr-23-3465 · 2024 · External reference
10.1038/s41570-025-00784-6
10.1038/s41570-025-00784-6 · 2026 · External reference
10.1021/acs.jmedchem.4c01017
10.1021/acs.jmedchem.4c01017 · 2024 · External reference
10.3390/molecules29174048
10.3390/molecules29174048 · 2024 · External reference
Unresolved reference
External reference
10.1056/nejmoa2505725
10.1056/nejmoa2505725 · 2025 · External reference
Unresolved reference
External reference
10.1200/jco.22.00338
10.1200/jco.22.00338 · 2022 · External reference
10.1634/theoncologist.7-6-477
10.1634/theoncologist.7-6-477 · 2002 · External reference
10.1021/acs.jmedchem.5c03330
10.1021/acs.jmedchem.5c03330 · 2026 · External reference
